Omnipaque 350 MG/ML infu BTL 150ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7WVW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,263
Award facts
- Contract value 100% obligated
- $10,262.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,262.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml intravenous bottles (150 ml units). The contract, awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a non-set-aside competitive procurement executed through the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems.
This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc., holds a significant related IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031. These comprehensive contract vehicles enable the company to supply a wide range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs and the Defense Health Agency globally. The short completion timeline for this particular delivery order reflects the urgent medical supply needs typical of federal healthcare procurement operations.
Quick answers
Who was awarded contract SPE2DR26F7WVW?
SPE2DR26F7WVW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F7WVW worth?
The government has obligated $10,263 on SPE2DR26F7WVW.
Is contract SPE2DR26F7WVW an order under another contract?
Yes. SPE2DR26F7WVW is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WVW competed?
The extent of competition for SPE2DR26F7WVW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award